Germany · Delayed Price · Currency is EUR Brenntag SE Earnings Call Transcripts
Fiscal Year 2025
-
2025 saw revenue and earnings decline amid persistent market weakness, but gross profit margins and free cash flow improved. Cost savings exceeded targets, and the outlook for 2026 remains cautious with continued focus on efficiency and cash preservation.
-
Q3 2025 saw lower sales and earnings amid persistent market weakness, but cost savings and cash flow improved. The company halted its planned split, focusing on operational efficiency, cost containment, and leveraging group synergies, with guidance now at the lower end of the range.
-
Q2 2025 saw a 4% sales decline and 14% lower EBITDA amid economic uncertainty, FX headwinds, and pricing pressure, especially in Essentials. Guidance for 2025 EBITDA was lowered, with continued weak demand and risks from tariffs and FX. July showed some improvement, but outlook remains cautious.
-
Q1 2025 results were stable year-over-year, with sales at EUR 4.1 billion and operating gross profit up 2%, but ongoing economic uncertainty, FX headwinds, and tariff risks are expected to keep full-year earnings at the lower end of guidance. Cost containment and segment strategies remain on track.
Fiscal Year 2024
-
2024 saw stable gross profit but lower sales and EBITDA amid challenging markets and inflation. Cost savings, portfolio optimization, and M&A were key, with a stable dividend proposed. 2025 guidance anticipates moderate volume and pricing improvements, but risks remain high.
-
Q3 2024 saw modest sales and gross profit growth but a decline in EBITA and EPS due to competitive pressures and portfolio changes. Cost containment and portfolio optimization remain priorities, with full-year EBITA guidance confirmed at the lower end of the range.
-
Q2 2024 saw sales decline 2% year-over-year to €4.2 billion, with operating EBITA down 10% to €297 million, but sequential volume recovery and margin initiatives stabilized gross profit per unit. Outlook for 2024 remains cautious amid pricing pressure, with EBITA guidance at €1.1–1.2 billion.